Thank you to the person who bought my share this morning .. lol
sold at a loss of 25% roughly....
company has $5m employee expense (in addition to research) for the revenue of $5m and NTA down to 3c from 6c previous financial year ... with 2 product sitting on shelf fully approved by FDA for almost a year but not on market ... compelled me to recover my 75% of my principal ... IMO... Good luck to those hanging in there ... !
Ann: Appendix 4E and FY22 Annual Report, page-2
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
